drugset / Trial / NCT01119287
Assessing the Efficacy of Maxidex® and Patanol® for the Treatment of Allergic Conjunctivitis
RandomizedParallel-groupDouble-blindDiagnostic
Summary
The purpose of this study was to evaluate the efficacy of Maxidex and Patanol compared to placebo in patients with allergic conjunctivitis when exposed to controlled allergen levels in an Environmental Exposure Chamber (EEC).
Timeline
- Start
- 2010-03
- Primary completion
- 2010-09
- Completion
- 2010-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dexamethasone | Small molecule | 0.1 % | Other |
| Subject | Olopatadine | Other / unclassified | 0.1 % | Other |